The trouble with Ostarine: Jimmy Wallhead’s
16th March 2018
USADA announced today that Jeff Schwab, of Bullard, Texas, an athlete in the sport of cycling, has tested positive for a prohibited substance and accepted a two-year sanction for his anti-doping rule violation. Schwab was tested in-competition as a result of being among the top finishers in his event at the 2016 Tour of Corsicana Bike Race in Corsicana, Texas.
Schwab, 45, provided an in-competition urine sample on March 13, 2016, at the Tour of Corsicana Bike Race as a part of the RaceClean Program that works to fight doping at the amateur level of cycling. The goal of the RaceClean Program is to increase testing and education at the amateur level to provide greater doping deterrence, and this USA Cycling program is executed through member funding, donations, and local association partnerships.
Schwab’s sample tested positive for the presence of an exogenous testosterone and/or its metabolites, which was confirmed by Isotope Ratio Mass Spectrometry (IRMS) analysis. Every urine sample that USADA collects is scrutinized under an Athlete Biological Passport program that examines levels of multiple steroid biomarkers that can indicate doping. Samples that exhibit atypical qualities are then targeted for more sophisticated IRMS analyses, which can reveal the presence of a synthetic, prohibited, anabolic agent. Schwab subsequently admitted his use of the anabolic agent under the care of a physician.
The use of any exogenous anabolic agent, including testosterone, is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the Union Cycliste Internationale Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
After a thorough review of the case, including Schwab’s medical records, USADA has accepted his explanation that the prohibited substance detected in his sample was contained within a prescribed medication he was taking in a therapeutic dose under the care of a qualified physician without the intent to enhance his athletic performance. However, Schwab lacked a valid Therapeutic Use Exemption (TUE).
Although an athlete may be prescribed a prohibited substance by a physician, it is important to understand that a prescription in and of itself does not authorize the use of a prohibited substance in sport. Under the USADA TUE Policy, an athlete has the responsibility to demonstrate in advance of using a prohibited substance that the use is medically legitimate and will not create a performance enhancing advantage. It is also important for athletes and the physicians who treat them to understand that powerful drugs like testosterone cannot be appropriately used in sport without advance authorization in order to ensure that use of them, even under the care of a physician, does not give an athlete an unfair advantage over fellow competitors.
Schwab’s two-year period of ineligibility began on March 13, 2016, the date his positive sample was collected. Although Schwab’s positive test was caused by his use of a prescribed medication, USADA determined that a two-year sanction was appropriate based on the fact that testosterone is a non-specified substance and the athlete lacked a TUE for this substance that is prohibited at all times. In addition, Schwab has been disqualified from all competitive results obtained on and subsequent to March 13, 2016, including forfeiture of any medals, points, and prizes.
• This media release was originally published by the US Anti-Doping Agency (USADA) on 8 September 2016. To access the original, please click here.
David Howman, former Director General of the World Anti-Doping Agency (WADA), has cast doubt on...